Dilfuza Kurbanbekova

1 works

1. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan

   Sheila Raghavan, Tamar Tsereteli, A. Kamilov +5

   ArticleReproductive Health and ContraceptionThe European Journal of Contraception & Reproductive Health Care20130 citations

   ABIABI:AkademIndex/openalex/2013.article.000062